RecruitingNot ApplicableNCT06584318

Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

Exploratory Study of the Impact of Intermittent Hypoxia Intervention on Patients With Colorectal Cancer

Sponsor

Capital Medical University

Enrollment

20 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Colorectal, Cancer

Summary

This study aims to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This exploratory study is testing whether brief periods of controlled low-oxygen exposure (intermittent hypoxia — similar to high-altitude conditions) can help people with early-stage colorectal cancer by potentially improving their body's response to treatment and recovery. **You may be eligible if...** - You have been diagnosed with colorectal cancer (stage I or II) - You are between 18 and 65 years old - You or your legal representative can provide informed consent **You may NOT be eligible if...** - You have a history of heart disease, stroke, or serious blood disorders - You have significant lung, liver, kidney, or skin conditions - You are pregnant - You have other serious health conditions that make the low-oxygen intervention unsafe - You are currently enrolled in another clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntermittent hypoxia intervention

The intermittent hypoxia protocol refers to 6 cycles of 10 minutes hypoxia inhaling interval by 5 minutes normoxia, which is performed twice a day (at least 6 hours apart) in 7 days.